BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22244474)

  • 1. Prevalence of hyperprolactinemia in adolescents and young women with menstruation-related problems.
    Lee DY; Oh YK; Yoon BK; Choi D
    Am J Obstet Gynecol; 2012 Mar; 206(3):213.e1-5. PubMed ID: 22244474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of menstruation-related problems for adolescents and premarital women in Korea.
    Shin SY; Lee YY; Yang SY; Yoon BK; Bae D; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):236-42. PubMed ID: 16054969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of determining serum levels of prolactin in women with menstruation disorders].
    Starzewski J; Niespodziański K; Kowalski D; Kowalska K; Piasek G; Chlewicka B
    Przegl Lek; 1989; 46(10):728-31. PubMed ID: 2594991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of hyperprolactinemia and galactorrhea in patients with abnormal uterine bleeding.
    Eftekhari N; Mirzaei F; Karimi M
    Gynecol Endocrinol; 2008 May; 24(5):289-91. PubMed ID: 18569035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
    Smith S
    J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is the assessment of biological activity of prolactin essential in the diagnosis of hyperprolactinemia?].
    Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
    Pol Merkur Lekarski; 2010 May; 28(167):359-61. PubMed ID: 20568397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J; Aldrighi JM; de Lima GR
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of endocrinologic diagnosis in sterility patients. A clinical report of experiences].
    Melzer H; Uhlmann G
    Zentralbl Gynakol; 1985; 107(16):989-95. PubMed ID: 3931388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rational hormonal diagnosis of oligomenorrhea].
    Weise HC; Moltz L; Bispink G; Leidenberger F
    Geburtshilfe Frauenheilkd; 1989 Aug; 49(8):694-700. PubMed ID: 2529165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
    Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
    J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective follow-up of menstrual disorders in adolescence and prognostic factors.
    Wiksten-Almströmer M; Hirschberg AL; Hagenfeldt K
    Acta Obstet Gynecol Scand; 2008; 87(11):1162-8. PubMed ID: 18956264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperprolactinemia--a significant factor in female infertility.
    Kredentser JV; Hoskins CF; Scott JZ
    Am J Obstet Gynecol; 1981 Feb; 139(3):264-7. PubMed ID: 7468693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent menstrual irregularity.
    Mansfield MJ; Emans SJ
    J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of menstrual function in young Nigerian athletes.
    Toriola AL
    Int J Sports Med; 1988 Feb; 9(1):29-34. PubMed ID: 3366516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
    Can M; Guven B; Atmaca H; Acıkgoz S; Mungan G
    Kaohsiung J Med Sci; 2011 May; 27(5):173-6. PubMed ID: 21527183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive personal experience. Validation of prolactin levels in menstrual disorders and in prolactinomas.
    Batrinos ML
    Hormones (Athens); 2009; 8(4):258-66. PubMed ID: 20045798
    [No Abstract]   [Full Text] [Related]  

  • 19. Headache, hyperprolactinemia, and prolactinomas.
    Strebel PM; Zacur HA; Gold EB
    Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility.
    Souter I; Baltagi LM; Toth TL; Petrozza JC
    Fertil Steril; 2010 Aug; 94(3):1159-62. PubMed ID: 20116788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.